Organon said on Wednesday it will discontinue the development of its experimental drug, after it failed to reduce pain in women suffering from endometriosis in a mid-stage study.

Organon said on Wednesday it will the stop development of an experimental treatment it acquired through its purchase of Forendo Pharma, after the drug failed to reduce pelvic pain in women with ...

While speaking with ClutchPoints, a trusted source revealed potential solutions for Paige Bueckers' lingering knee injury.

The study uncovers how ovarian ECM tropism influences endometriotic cell adhesion, paving the way for novel strategies to ...

Elmiron® was approved without clear proof of effectiveness and is now tied to progressive retinal and gastrointestinal damage ...